PAM
CBIO

Panagora Asset Management’s Crescent Biopharma CBIO Stock Holding History

Panagora Asset Management’s Portfolio CBIO Stock Details CBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-651
Closed -$196K – 2843
2021
Q1 		$196K Sell
651
-411
-39% -$147K ﹤0.01% 1727
2020
Q4 		$399K Sell
1,062
-727
-41% -$255K ﹤0.01% 1315
2020
Q3 		$549K Sell
1,789
-2
-0.1% -$764 ﹤0.01% 1126
2020
Q2 		$673K Sell
1,791
-172
-9% -$48.7K ﹤0.01% 1085
2020
Q1 		$447K Buy
1,963
+780
+66% +$298K ﹤0.01% 1170
2019
Q4 		$626K Buy
+1,183
New +$640K ﹤0.01% 1225
2016
Q3 		– Sell
-81
Closed -$59K – 2431
2016
Q2 		$59K Buy
+81
New +$55.8K ﹤0.01% 2028
2014
Q2 		– Sell
-647
Closed -$1.06M – 2346
2014
Q1 		$1.06M Buy
+647
New +$783K 0.01% 1156

Other funds holding CBIO

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return